Skip to main content

Cardiomyopathies and Clinical Features

  • Chapter
  • First Online:
Mechanical Circulatory Support in End-Stage Heart Failure
  • 1826 Accesses

Abstract

Heart failure (HF) is the end-stage scenario common to all different types of cardiomyopathies. It is characterized by an imbalance between the oxygen delivered by the cardiac output and the need of peripheral organs and tissues [1]. However, the clinical picture, the time course of its occurrence, and its treatment can vary according to the different underlying diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ponikowski P et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200

    Article  PubMed  Google Scholar 

  2. Owan TE, Hodge DO, Herges RM et al (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259

    Article  CAS  PubMed  Google Scholar 

  3. Kirklin JK et al (2015) Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 34(12):1495–1504

    Article  PubMed  Google Scholar 

  4. Elliott P, Andersson B et al (2008) Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270–276

    Article  PubMed  Google Scholar 

  5. Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39

    Article  PubMed  Google Scholar 

  6. Grigioni F et al (2005) Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. J Am Coll Cardiol 45(2):260–267

    Article  PubMed  Google Scholar 

  7. Piano MR (2002) Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 121:1638–1650

    Article  PubMed  Google Scholar 

  8. Cerqueira MD et al (1991) Rarity of preclinical alcoholic cardiomyopathy in chronic alcoholics less than 40 years of age. Am J Cardiol 67:183–187

    Article  CAS  PubMed  Google Scholar 

  9. Bovelli D et al (2010) Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. Ann Oncol 21:v277–v282

    Article  PubMed  Google Scholar 

  10. Kindermann I et al (2012) Update on myocarditis. J Am Coll Cardiol 59:779–792

    Article  PubMed  Google Scholar 

  11. McCarthy RE et al (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690–695

    Article  PubMed  Google Scholar 

  12. Grody WW et al (1990) Infection of the heart by the human immunodeficiency virus. Am J Cardiol 66:203–206

    Article  CAS  PubMed  Google Scholar 

  13. Raidel SM et al (2002) Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol Heart Circ Physiol 282:H1672–H1678

    Article  CAS  PubMed  Google Scholar 

  14. Kransdorf EP, Zakowski PC, Kobashigawa JA (2014) Chagas isease in solid organ and heart transplantation. Curr Opin Infect Dis 27(5):418–424

    Article  PubMed  Google Scholar 

  15. Elkayam U et al (2001) Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344:1567–1571

    Article  CAS  PubMed  Google Scholar 

  16. Gujja P et al (2010) Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol 56:1001–1012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Srichai MB et al (2011) Cardiac sarcoidosis. J Am Coll Cardiol 58:438

    Article  PubMed  Google Scholar 

  18. Elliott P et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J 35:2733–2779

    Article  PubMed  Google Scholar 

  19. Biagini E et al (2014) Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy. Am J Cardiol 114(5):769–776

    Article  CAS  PubMed  Google Scholar 

  20. Quarta CC et al (2014) Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation 129(18):1840–1849

    Article  PubMed  Google Scholar 

  21. Potena L et al (2014) Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. J Heart Lung Transplant 33(2):136–138

    Article  PubMed  Google Scholar 

  22. Reich HJ et al (2015) Combined heart and liver transplantation: the Cedars-Sinai experience. Transplant Proc 47(9):2722–2726

    Article  CAS  PubMed  Google Scholar 

  23. Basso C et al (2009) Arrhythmogenic right ventricular cardiomyopathy. Lancet 373(9671):1289–1300

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Grigioni .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Grigioni, F., Potena, L., Marinelli, G., Masetti, M. (2017). Cardiomyopathies and Clinical Features. In: Montalto, A., Loforte, A., Musumeci, F., Krabatsch, T., Slaughter, M. (eds) Mechanical Circulatory Support in End-Stage Heart Failure. Springer, Cham. https://doi.org/10.1007/978-3-319-43383-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43383-7_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43381-3

  • Online ISBN: 978-3-319-43383-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics